Search: id:"swepub:oai:lup.lub.lu.se:7ec74219-66c4-4db5-9457-0d25926e0b70" >
Tasquinimod Is an A...
Tasquinimod Is an Allosteric Modulator of HDAC4 Survival Signaling within the Compromised Cancer Microenvironment
- Article/chapterEnglish2013
Publisher, publication year, extent ...
Numbers
-
LIBRIS-ID:oai:lup.lub.lu.se:7ec74219-66c4-4db5-9457-0d25926e0b70
-
https://lup.lub.lu.se/record/3577906URI
-
https://doi.org/10.1158/0008-5472.CAN-12-2730DOI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:art swepub-publicationtype
-
Subject category:ref swepub-contenttype
Notes
-
Tasquinimod is an orally active antiangiogenic drug that is currently in phase III clinical trials for the treatment of castration-resistant prostate cancer. However, the target of this drug has remained unclear. In this study, we applied diverse strategies to identify the histone deacetylase HDAC4 as a target for the antiangiogenic activity of tasquinimod. Our comprehensive analysis revealed allosteric binding (Kd 10-30 nmol/L) to the regulatory Zn2+ binding domain of HDAC4 that locks the protein in a conformation preventing HDAC4/N-CoR/HDAC3 complex formation. This binding inhibited colocalization of N-CoR/HDAC3, thereby inhibiting deacetylation of histones and HDAC4 client transcription factors, such as HIF-1 alpha, which are bound at promoter/enhancers where epigenetic reprogramming is required for cancer cell survival and angiogenic response. Through this mechanism, tasquinimod is effective as a monotherapeutic agent against human prostate, breast, bladder, and colon tumor xenografts, where its efficacy could be further enhanced in combination with a targeted thapsigargin prodrug (G202) that selectively kills tumor endothelial cells. Together, our findings define a mechanism of action of tasquinimod and offer a perspective on how its clinical activity might be leveraged in combination with other drugs that target the tumor microenvironment. Cancer Res; 73(4); 1386-99. (C) 2012 AACR.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Antony, Lizamma
(author)
-
Dalrymple, Susan L.
(author)
-
Brennen, W. Nathaniel
(author)
-
Gerber, Stephanie
(author)
-
Hammers, Hans
(author)
-
Wissing, Michel
(author)
-
Kachhap, Sushant
(author)
-
Luo, Jun
(author)
-
Xing, Li
(author)
-
Bjork, Per
(author)
-
Olsson, Anders
(author)
-
Bjork, Anders
(author)
-
Leanderson, TomasLund University,Lunds universitet,Immunologi,Forskargrupper vid Lunds universitet,Immunology,Lund University Research Groups(Swepub:lu)immu-tle
(author)
-
ImmunologiForskargrupper vid Lunds universitet
(creator_code:org_t)
Related titles
-
In:Cancer Research74:4, s. 1386-13991538-7445
Internet link
Find in a library
To the university's database
- By the author/editor
-
Isaacs, John T.
-
Antony, Lizamma
-
Dalrymple, Susan ...
-
Brennen, W. Nath ...
-
Gerber, Stephani ...
-
Hammers, Hans
-
show more...
-
Wissing, Michel
-
Kachhap, Sushant
-
Luo, Jun
-
Xing, Li
-
Bjork, Per
-
Olsson, Anders
-
Bjork, Anders
-
Leanderson, Toma ...
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Basic Medicine
-
and Immunology in th ...
- Articles in the publication
-
Cancer Research
- By the university
-
Lund University